Immunoreactivity of p53 in Urothelial Carcinomas of the Urinary Bladder
Introduction: Urothelial Carcinomas (UC) are heterogenous disease with unpredictable outcome. Risk stratification plays an important role in the management as 70% tumours are NonMuscle Invasive (NMI) at the time of diagnosis. It is difficult to make prognosis for individual patients due to high r...
Main Authors: | Vasudha Nassa, Asha Mahadevappa |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Pvt. Ltd.
2018-10-01
|
Series: | National Journal of Laboratory Medicine |
Subjects: | |
Online Access: | http://www.njlm.net/articles/PDF/2324/39790_CE[Ra1]_F(SHU)_PF1(A_SHU)_PFA(A_SHU)_PN(SHU).pdf |
Similar Items
-
Role of p53 and Ki-67 immunomarkers in carcinoma of urinary bladder
by: Brijesh Thakur, et al.
Published: (2017-01-01) -
Upper urinary tract urothelial carcinoma experimental models
by: Leonardo Oliveira Reis, et al.
Published: (2009-12-01) -
Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
by: Daniele Minardi, et al.
Published: (2016-03-01) -
Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer
by: Lampros Mitrakas, et al.
Published: (2021-06-01) -
ETS-1 oncoprotein expression is decreased in aggressive papillary transitional cell carcinoma of the urinary bladder: An immunohistochemical study
by: E.A. Ibrahim, et al.
Published: (2017-06-01)